Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oocyte-secreted protein 2 (OOSP2) is a secreted protein highly translated in human oocytes, functioning as an autocrine factor to promote oocyte maturation[1][3][4][7]. Its expression is driven by regulatory motifs in its 3′-UTR and translational activation via polyadenylation and cytoplasmic polyadenylation elements, primarily CPEB4[1]. OOSP2 is co-expressed with key maturation regulators like BMP15[1]. Experimentally, recombinant OOSP2 accelerates oocyte maturation and blockade by antibodies or knockdown inhibits this process[1]. It upregulates translation of mRNAs involved in small GTPase signaling, organelle localization, and cellular events critical for oocyte development[1]. There is no evidence of therapeutic targeting or clear disease association for OOSP2 at this time; research primarily focuses on its role in reproductive biology and embryo development[1][3][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oocyte-secreted protein 2 (OOSP2).